TRODELVY subst sèche 180 mg flac

7680681790013 CH-68179 L01FX17 07.16.1.

Active substances:

TRODELVY subst sèche 180 mg flac
TRODELVY subst sèche 180 mg flac
TRODELVY subst sèche 180 mg flac
1 / 3
google

Details

Product number
6817901
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: sacituzumabum govitecanum 180 mg, acidum morpholinoethansulfonicum, trehalosum dihydricum, polysorbatum 80, pro vitro.

Articles (1)

TRODELVY 180 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
14/02/2026
Professional SmPC
Français
14/02/2026
Professional SmPC
Italien
14/02/2026

Detailed composition

Substance Quantity Type Category
sacituzumabum govitecanum
180.0 MG Substance Wirkstoff (Principe actif)
acidum morpholinoethansulfonicum
- Substance HNIDK
trehalosum dihydricum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK

Reimbursement information

Public price
CHF 1021.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2022

Authorization holder

Gilead Sciences Switzerland Sàrl

6300 Zug

Authorization information

Swissmedic authorization number
68179
Drug name
TRODELVY, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPI
ATC Code
L01FX17
Authorization status
Z
Dispensation category
A
First authorization
09/09/2021
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Mammakarzinom

Packaging details

Description (FR)
TRODELVY subst sèche 180 mg flac
Description (DE)
TRODELVY Trockensub 180 mg Durchstf
Market launch
09/09/2021
Narcotic (BTM)
No
Buy us a coffee Explore the data